Details

NameSymbolSector
ERIS LIFESCIENCES LIMITEDERISPharmaceuticals
Open
1674.8
High
1700
Low
1664
Close
1684.5
Volume
35807
Exchange
nse
Time
14/08

Outlook

Score:  

1.5

Rating:  

RISKY

Candlestick Pattern

Candle pattern of Eris Lifesciences is  
Short Line
Estimated Stoploss of Eris Lifesciences is ₹  
1664
Eris Lifesciences has a  
Bullishℹ
 pattern. 
Formation of  
Short Line
 candle pattern indicates the trend direction of Eris Lifesciences is  
Unpredictableℹ
. 

Trend

Eris Lifesciences is in  
Downtrendℹ
. 
Price of Eris Lifesciences is  
Downℹ
 by  

2.78

%. 
Target
Buy @ 

1610.5

Sell @ 

1745.5

Volume

The trade volumes of Eris Lifesciences have become  
Deficientℹ
The volume trend for Eris Lifesciences is  
Bearishℹ
, but the participants are  
Weak Sellersℹ
The trade volume of Eris Lifesciences is  

Down

 by  

84.52

% 

Valuation

The current market price of Eris Lifesciences is  
Overvaluedℹ

Financials

Balance
The balance sheet of Eris Lifesciences is:  

Balanced

Cashflow
Eris Lifesciences has  
Excellentℹ
 cash flow because there is  

Surplus

 of  

₹ 105cr

. It is  
Upℹ
 by  

854.55

%. 

(*Mar 2025)

52.57% i.e. ₹ 1065cr earned in operatingℹ
3.9% i.e. ₹ 79cr spent in investingℹ
43.48% i.e. ₹ 881cr spent in financingℹ
0.05% i.e. ₹ 1cr earned in otherℹ
Eris Lifesciences has  
Excellentℹ
 cash flow because there is  

Surplus

 of  

₹ 11cr

. It is  
Upℹ
 by  

120

%. 

(*Mar 2024)

13.07% i.e. ₹ 486cr earned in operatingℹ
49.85% i.e. ₹ 1854cr spent in investingℹ
37.08% i.e. ₹ 1379cr earned in financingℹ
0% in otherℹ
Income
The income of Eris Lifesciences is  

₹ 775cr

 and  

Profit

 is :  

₹ 124cr

(*Jun 2025)

Eris Lifesciences Profit is up by:  

21.57

% and Income is Up by:  

8.7

% 

(*Jun 2025)

The income of Eris Lifesciences is  

₹ 713cr

 and  

Profit

 is :  

₹ 102cr

(*Mar 2025)

Eris Lifesciences Profit is up by:  

18.6

% and Income is Down by:  

2.46

% 

(*Mar 2025)

The income of Eris Lifesciences is  

₹ 731cr

 and  

Profit

 is :  

₹ 86cr

(*Dec 2024)

Eris Lifesciences Profit is down by:  

10.42

% and Income is Down by:  

1.88

% 

(*Dec 2024)

By using this site you agree to the use of cookies to deliver a better site experience.